Amyloid beta peptide is an important biomarker in Alzheimer's disease, with the
amyloidogenic hypothesis as one of the central hypotheses trying to explain this type of …

Alzheimerʼs disease (AD), an age‐related neurodegenerative disease, is a striking global
health problem. Ferroptosis is a newly discovered form of cell death characterized by iron …

Alzheimer's Disease (AD) is the leading form of dementia worldwide. Currently, the
pathological mechanisms underlying AD are not well understood. Although the …

Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the nervous
system. The GABA signaling system in the brain is comprised of GABA synthesizing …

Alzheimer's disease (AD) is a neurodegenerative disorder with an increasing need for
developing disease-modifying treatments as current therapies only provide marginal …

Two of the most prevalent neurodegenerative disorders (NDDs), Alzheimer's disease (AD)
and Parkinson's disease (PD), present significant challenges to healthcare systems …

Abstract Alzheimer's disease (AD), the most common chronic neurodegenerative disorder,
has complex neuropathology. The principal neuropathological hallmarks of the disease are …

Alzheimer's disease (AD) is a neuropathological disorder characterized by the presence and
accumulation of amyloid-beta plaques and neurofibrillary tangles. Glutamate dysregulation …

Alzheimer's disease (AD), the most common chronic neurodegenerative disorder, has
complex neuropathology. The principal neuropathological hallmarks of the disease are the …

Alzheimer's disease (AD) is a chronic neurodegenerative disease affecting the elderly. AD is
associated with a progressive decline in memory and cognitive abilities, drastic changes in …